Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients-Reference-Cited by-同舟云学术

Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients

Published:2011-05 Issue:9 Volume:107 Page:1375-1380
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Sawaya Heloisa,Sebag Igal A.,Plana Juan Carlos,Januzzi James L.,Ky Bonnie,Cohen Victor,Gosavi Sucheta,Carver Joseph R.,Wiegers Susan E.,Martin Randolph P.,Picard Michael H.,Gerszten Robert E.,Halpern Elkan F.,Passeri Jonathan,Kuter Irene,Scherrer-Crosbie Marielle

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations;Martin;Oncologist,2009

2. Left ventricle I: general considerations, assessment of chamber size and function;Vuille,1994

3. Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range;Marwick;J Am Coll Cardiol Cardiovasc Imaging,2009

4. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

5. Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study;Bengala;Br J Cancer,2006

Cited by 554 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into cardioprotection in breast cancer patients undergoing physical exercise during chemotherapy: A systematic review and meta-analysis;Current Problems in Cardiology;2024-10

2. Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking echocardiography;Revista Portuguesa de Cardiologia;2024-08

3. Trastuzumab-Induced Cardiotoxicity: When and How Much Should We Worry?;JCO Oncology Practice;2024-08

4. Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold story;Progress in Cardiovascular Diseases;2024-07

5. Assessment of cardiotoxicity in cancer patients on chemotherapy in a low resource setting: is echocardiography the ultimate tool, or should we look for another?;Annals of Clinical and Biomedical Research;2024-06-28